INBORN-ERRORS OF DRUG-METABOLISM - PHARMACOKINETIC AND CLINICAL IMPLICATIONS

被引：10

作者：

LENNARD, MS

TUCKER, GT

WOODS, HF

机构：

[1] Department of Medicine and Pharmacology, University of Sheffield, Royal Hallamshire Hospital, Sheffield

[2] University Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield

来源：

CLINICAL PHARMACOKINETICS | 1990年 / 19卷 / 04期

关键词：

D O I：

10.2165/00003088-199019040-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：257 / 263

页数：7

共 77 条

[1] PHARMACOGENETICS OF ALCOHOL-DEHYDROGENASE (ADH) [J].

AGARWAL, DP ;

GOEDDE, HW .

PHARMACOLOGY & THERAPEUTICS, 1990, 45 (01) :69-83

[2] GENETIC FACTORS RELATED TO GLAUCOMA [J].

ARMALY, MF .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 151 (A2) :861-&

[3] GENETIC-POLYMORPHISM OF TRIMETHYLAMINE N-OXIDATION [J].

AYESH, R ;

SMITH, RL .

PHARMACOLOGY & THERAPEUTICS, 1990, 45 (03) :387-401

[4] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].

AYESH, R ;

IDLE, JR ;

RITCHIE, JC ;

CROTHERS, MJ ;

HETZEL, MR .

NATURE, 1984, 312 (5990) :169-170

[5] GENETIC-FACTORS INFLUENCING THE METABOLISM OF TOLBUTAMIDE [J].

BACK, DJ ;

ORME, ML .

PHARMACOLOGY & THERAPEUTICS, 1989, 44 (02) :147-155

[6] ALTERED DISTRIBUTION OF DEBRISOQUINE OXIDATION PHENOTYPES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

BAER, AN ;

MCALLISTER, CB ;

WILKINSON, GR ;

WOOSLEY, RL ;

PINCUS, T .

ARTHRITIS AND RHEUMATISM, 1986, 29 (07) :843-850

[7]

BAI TR, 1982, J ROY COLL PHYS LOND, V16, P239

[8]

BARBEAU A, 1985, LANCET, V2, P1213

[9]

BERTILSSON L, 1981, LANCET, V1, P560

[10]

BONICKE R, 1953, ARCH EXP PATHOL PH, V220, P321

← 1 2 3 4 5 6 7 8 →